Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEIR-PEP: Epinephrine Injection vs Rectal Indomethacin for Preventing Post-ERCP Pancreatitis
NCT07173179Phase 4Completed
- Sponsor
- Düzce University
- Start
- Jan 2023
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of epinephrine in acute pancreatitis (AP), sponsored by Düzce University. Started Jan 2023; status: completed.
02
Drugs
epinephrine
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT07173179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07173179.